Related by context. Frequent words. (Click for all words.) 66 Initiates Phase 63 Abstract Number 62 Metastatic Melanoma 61 Nephrol 61 J Natl Cancer Inst 61 Pivotal Phase 60 Completes Enrollment 60 J Clin Psychiatry 60 Arch Neurol 60 Suppl 59 Clinical Trial Results 59 J Biol Chem 59 Am J Epidemiol 59 multicenter Phase 59 Pivotal Phase III 59 Phase Ib clinical 59 KRN# 59 J Am Acad 58 Arch Pediatr Adolesc Med 58 Ofatumumab 58 Obstet Gynecol 58 humanized monoclonal antibody 58 liposomal formulation 58 Announces Initiation 58 J Clin Oncol 57 Psychol 57 Bortezomib 57 Med Assoc 57 Free Full Text 57 Phase III Clinical Trial 57 Traficet EN 57 selective inhibitor 56 relapsed refractory multiple myeloma 56 #:#-# [025] 56 Br J Psychiatry 56 Ann Intern Med 56 Arch Gen Psychiatry 56 ZFP Therapeutic 56 relapsing multiple sclerosis 56 Am J Clin 56 S# S# [001] 56 #:#-# [031] 56 Phase III Trial 56 Phase 1b clinical 56 drug conjugate 56 Clin Infect Dis 56 Oncol 56 MKC# 55 romidepsin 55 DDP# 55 Tenn. Ct 55 placebo controlled Phase 55 Guanilib 55 Monoclonal Antibody 55 phase IIb clinical 55 J Med 55 SCH # 55 Phase 2a clinical 55 Physiol 55 J Clin Endocrinol Metab 55 Proc Natl Acad Sci 55 StemEx 55 Pivotal Trial 54 Clinical Study 54 Article PubMed ISI ChemPort 54 Biol Psychiatry 54 Arch Intern Med 54 Nutr 54 phase 2a 54 # et seq 54 IMMU 54 orally bioavailable 54 elotuzumab 54 tolerated dose MTD 54 confirmatory Phase III 54 CCX# 54 #:#-# [006] 54 RU EUROPE EEU EMRG 54 Fibrillex TM 54 Phase IIa clinical 54 Cancer Res 53 multicenter randomized double 53 ATTAIN 53 Phase 1b 53 Phase 1b trial 53 PIA XI top 53 PARP inhibitor 53 tanespimycin 53 Resp 53 Dasatinib 53 forodesine 53 Phase IIa clinical trials 53 SB 53 dose escalation trial 53 Irinotecan 53 HGS ETR1 53 Phase Ib 53 phase IIa 53 Guides FY# Quick Facts 53 #:#-# [001] 52 luteinizing hormone releasing